CAREY STEPHEN P. 4

What Happened
Stephen P. Carey, Senior Vice President & Chief Financial Officer of ANI Pharmaceuticals (ANIP), was granted a restricted stock award of 22,233 shares on 2026-02-26 at a grant value of $77.15 per share (total value ≈ $1,715,276). A related tax-withholding disposition of 2,773 shares occurred on 2026-02-28 at $73.90 per share (proceeds ≈ $204,925).

Key Details

• Grant (A): 22,233 restricted shares @ $77.15 on 2026-02-26 — total grant value ≈ $1,715,276.
• Tax withholding (F): 2,773 shares disposed @ $73.90 on 2026-02-28 — value ≈ $204,925.
• Vesting: The newly granted restricted stock vests in four equal annual installments on the first, second, third and fourth anniversaries of 2026-02-26 (footnote F1).
• Tax withholding note: Footnote F2 indicates shares were withheld for tax purposes and the withholding is exempt under Rule 16b-3 in connection with the vesting of 6,079 previously reported restricted shares.
• Shares owned after transaction: not specified in the filing.
• Filing timeliness: Form 4 was filed 2026-03-02 for transactions on 2026-02-26 and 2026-02-28; the filing date appears to meet the standard two-business-day reporting window.

Context
This was a restricted stock grant (an award/acquisition), not an open-market purchase or exercise-and-sell. The tax-withholding disposition is routine when restricted shares vest or are delivered; the footnote indicates that withholding was handled in a manner exempt under Rule 16b-3, which is commonly used to satisfy tax obligations without creating a reportable short-swing profit exposure. The filing is purely informational about insider compensation and tax withholding and does not by itself indicate the executive’s market view.